NURS 3307 Pharmacology Exam 2 Blue Print Summer 2023 PDF
Document Details
Uploaded by CarefreeGallium
2023
Tags
Summary
This document is an exam blueprint for a pharmacology course, focusing on the hematologic, cardiovascular, and respiratory systems in the summer of 2023. It outlines the key topics, expected learning outcomes, and structure of the exam.
Full Transcript
**NURS 3307 Pharmacology Exam 2 Blue Print** **Summer 2023** +-----------------------+-----------------------+-----------------------+ | **Week 3: Hematologic | | | | System** | | | +==============...
**NURS 3307 Pharmacology Exam 2 Blue Print** **Summer 2023** +-----------------------+-----------------------+-----------------------+ | **Week 3: Hematologic | | | | System** | | | +=======================+=======================+=======================+ | **Pharm Made Easy** | **Therapeutic effect, | **10** | | | side/adverse effects, | | | | medication | | | | interactions, | | | | precautions/contraind | | | | ications, | | | | and nursing | | | | implications for:** | | +-----------------------+-----------------------+-----------------------+ | | **Drug Therapy for | 2 | | | Anemia** | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | **Drug Therapy for | 2 | | | Bleeding Disorders** | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | **Drug Therapy to | 5 | | | Prevent and Dissolve | | | | Thrombi** | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | **Drug Therapy that | 1 | | | Supports | | | | Hematopoiesis** | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | **Week 4: | | | | Cardiovascular | | | | System** | | | +-----------------------+-----------------------+-----------------------+ | **Pharm Made Easy** | **Therapeutic effect, | **23** | | | side/adverse effects, | | | | medication | | | | interactions, | | | | precautions/contraind | | | | ications, | | | | and nursing | | | | implications for:** | | +-----------------------+-----------------------+-----------------------+ | | **Drug Therapy for | 7 | | | Hypertension** | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | **Drug Therapy for | 7 | | | Heart Failure** | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | **Drug Therapy for | 5 | | | Coronary Artery | | | | Disease** | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | **Drug Therapy for | 4 | | | Cardiac | | | | Dysrhythmias** | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | **Week 5: Respiratory | | | | System** | | | +-----------------------+-----------------------+-----------------------+ | **Pharm Made Easy** | **Therapeutic effect, | **12** | | | side/adverse effects, | | | | medication | | | | interactions, | | | | precautions/contraind | | | | ications, | | | | and nursing | | | | implications for:** | | +-----------------------+-----------------------+-----------------------+ +-----------------------+-----------------------+-----------------------+ | | **Drug Therapy for | 6 | | | Lower Respiratory | | | | Airflow Disorders** | | +=======================+=======================+=======================+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | **Drug Therapy for | 6 | | | Upper Respiratory | | | | Disorders** | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ | | - | | +-----------------------+-----------------------+-----------------------+ **Dosage Calculations** **5** ------------------------- -- -------- **TOTAL** **50**
